Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors

Prostaglandins Leukot Essent Fatty Acids. 1996 Sep;55(3):207-10. doi: 10.1016/s0952-3278(96)90100-3.

Abstract

Cerebrodiene (cis-9, 10-octadecenoamide) was recently isolated from cerebral fluid of sleep-deprived cats and shown to induce sleep in rats. Because this lipid amide is related to arachidonylethanolamide (AEA), and because AEA binds to the cannabinoid receptor with high affinity, we investigated the binding affinity of cerebrodiene and some analogs to the cannabinoid receptor. In addition, we tested the ability of these compounds to act as cannabinoid receptor agonists by determining GTP gamma S binding. Each of the analogs competed for [3H] CP55940 binding, but with relatively low affinity (Ki = 26-44 microM). These analogs were not able to stimulate binding of GTP gamma S at concentrations of 100 microM or 1 mM. We conclude that the sleep-inducing actions of cerebrodiene are not mediated via activation of the cannabinoid receptor.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arachidonic Acids / chemistry
  • Arachidonic Acids / metabolism*
  • Binding, Competitive
  • Brain / metabolism*
  • Cannabinoids / metabolism*
  • Dose-Response Relationship, Drug
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • Rats
  • Receptors, Cannabinoid
  • Receptors, Drug / metabolism*
  • Sleep / physiology
  • Sphingosine / analogs & derivatives*
  • Sphingosine / chemistry
  • Sphingosine / metabolism
  • Structure-Activity Relationship

Substances

  • Arachidonic Acids
  • Cannabinoids
  • Endocannabinoids
  • Polyunsaturated Alkamides
  • Receptors, Cannabinoid
  • Receptors, Drug
  • cerebrodiene
  • Sphingosine
  • anandamide